PT1261367E - Utilizacao de antagonistas da interleucina 6 para o tratamento de tumores dependentes de estrogenios - Google Patents

Utilizacao de antagonistas da interleucina 6 para o tratamento de tumores dependentes de estrogenios

Info

Publication number
PT1261367E
PT1261367E PT00911250T PT00911250T PT1261367E PT 1261367 E PT1261367 E PT 1261367E PT 00911250 T PT00911250 T PT 00911250T PT 00911250 T PT00911250 T PT 00911250T PT 1261367 E PT1261367 E PT 1261367E
Authority
PT
Portugal
Prior art keywords
antagonists
treatment
interleukin
utilization
dependent tumors
Prior art date
Application number
PT00911250T
Other languages
English (en)
Portuguese (pt)
Inventor
Michael John Reed
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of PT1261367E publication Critical patent/PT1261367E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/204—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
PT00911250T 2000-03-06 2000-03-06 Utilizacao de antagonistas da interleucina 6 para o tratamento de tumores dependentes de estrogenios PT1261367E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IT2000/000072 WO2001066131A1 (en) 2000-03-06 2000-03-06 Use of interleukin-6 antagonists for the treatment of diseases characterised by high levels of aromatase

Publications (1)

Publication Number Publication Date
PT1261367E true PT1261367E (pt) 2005-09-30

Family

ID=11133493

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00911250T PT1261367E (pt) 2000-03-06 2000-03-06 Utilizacao de antagonistas da interleucina 6 para o tratamento de tumores dependentes de estrogenios

Country Status (17)

Country Link
US (1) US7160860B2 (https=)
EP (1) EP1261367B1 (https=)
JP (1) JP2003525906A (https=)
KR (1) KR100694005B1 (https=)
AT (1) ATE295735T1 (https=)
AU (1) AU2000233235A1 (https=)
CA (1) CA2400711A1 (https=)
CZ (1) CZ20022760A3 (https=)
DE (1) DE60020269T2 (https=)
DK (1) DK1261367T3 (https=)
ES (1) ES2241583T3 (https=)
HU (1) HUP0300117A3 (https=)
MX (1) MXPA02008697A (https=)
PL (1) PL356846A1 (https=)
PT (1) PT1261367E (https=)
SK (1) SK12412002A3 (https=)
WO (1) WO2001066131A1 (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6793678B2 (en) 2002-06-27 2004-09-21 Depuy Acromed, Inc. Prosthetic intervertebral motion disc having dampening
US8105382B2 (en) 2006-12-07 2012-01-31 Interventional Spine, Inc. Intervertebral implant
US8900307B2 (en) 2007-06-26 2014-12-02 DePuy Synthes Products, LLC Highly lordosed fusion cage
EP2471493A1 (en) 2008-01-17 2012-07-04 Synthes GmbH An expandable intervertebral implant and associated method of manufacturing the same
CN102036623A (zh) 2008-04-05 2011-04-27 斯恩蒂斯有限公司 可膨胀的椎间植入体
US9526620B2 (en) 2009-03-30 2016-12-27 DePuy Synthes Products, Inc. Zero profile spinal fusion cage
US9393129B2 (en) 2009-12-10 2016-07-19 DePuy Synthes Products, Inc. Bellows-like expandable interbody fusion cage
US8979860B2 (en) 2010-06-24 2015-03-17 DePuy Synthes Products. LLC Enhanced cage insertion device
US9282979B2 (en) 2010-06-24 2016-03-15 DePuy Synthes Products, Inc. Instruments and methods for non-parallel disc space preparation
AU2011271465B2 (en) 2010-06-29 2015-03-19 Synthes Gmbh Distractible intervertebral implant
US9402732B2 (en) 2010-10-11 2016-08-02 DePuy Synthes Products, Inc. Expandable interspinous process spacer implant
US8394129B2 (en) 2011-03-10 2013-03-12 Interventional Spine, Inc. Method and apparatus for minimally invasive insertion of intervertebral implants
US8518087B2 (en) 2011-03-10 2013-08-27 Interventional Spine, Inc. Method and apparatus for minimally invasive insertion of intervertebral implants
WO2014018098A1 (en) 2012-07-26 2014-01-30 DePuy Synthes Products, LLC Expandable implant
US9717601B2 (en) 2013-02-28 2017-08-01 DePuy Synthes Products, Inc. Expandable intervertebral implant, system, kit and method
US9522070B2 (en) 2013-03-07 2016-12-20 Interventional Spine, Inc. Intervertebral implant
US11426290B2 (en) 2015-03-06 2022-08-30 DePuy Synthes Products, Inc. Expandable intervertebral implant, system, kit and method
US9913727B2 (en) 2015-07-02 2018-03-13 Medos International Sarl Expandable implant
WO2018002715A2 (en) 2016-06-28 2018-01-04 Eit Emerging Implant Technologies Gmbh Expandable and angularly adjustable articulating intervertebral cages
EP3474783B1 (en) 2016-06-28 2023-05-03 Eit Emerging Implant Technologies GmbH Expandable, angularly adjustable intervertebral cages
US10537436B2 (en) 2016-11-01 2020-01-21 DePuy Synthes Products, Inc. Curved expandable cage
US10888433B2 (en) 2016-12-14 2021-01-12 DePuy Synthes Products, Inc. Intervertebral implant inserter and related methods
US10398563B2 (en) 2017-05-08 2019-09-03 Medos International Sarl Expandable cage
US11344424B2 (en) 2017-06-14 2022-05-31 Medos International Sarl Expandable intervertebral implant and related methods
US10940016B2 (en) 2017-07-05 2021-03-09 Medos International Sarl Expandable intervertebral fusion cage
US11446156B2 (en) 2018-10-25 2022-09-20 Medos International Sarl Expandable intervertebral implant, inserter instrument, and related methods
US11426286B2 (en) 2020-03-06 2022-08-30 Eit Emerging Implant Technologies Gmbh Expandable intervertebral implant
US11850160B2 (en) 2021-03-26 2023-12-26 Medos International Sarl Expandable lordotic intervertebral fusion cage
US11752009B2 (en) 2021-04-06 2023-09-12 Medos International Sarl Expandable intervertebral fusion cage
US12090064B2 (en) 2022-03-01 2024-09-17 Medos International Sarl Stabilization members for expandable intervertebral implants, and related systems and methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1276555B1 (it) * 1995-04-28 1997-11-03 Angeletti P Ist Richerche Bio Antagonisti di interluchina-6 umana del tutto incapaci di formare un legame con gp 130, e loro uso per la preparazione di composizioni
IT1285790B1 (it) * 1996-09-24 1998-06-24 Angeletti P Ist Richerche Bio Adenovirus difettivi ricombinanti che codificano per mutanti di interleuchina 6 umana (hil-6) con attivita' antagonista o
GB9621095D0 (en) * 1996-10-09 1996-11-27 Imperial College Novel system
US7205280B2 (en) * 1998-03-11 2007-04-17 Cognosci, Inc. Methods of suppressing microglial activation

Also Published As

Publication number Publication date
HUP0300117A3 (en) 2005-09-28
KR20020079984A (ko) 2002-10-21
MXPA02008697A (es) 2003-04-14
HUP0300117A2 (hu) 2003-04-28
WO2001066131A1 (en) 2001-09-13
CZ20022760A3 (cs) 2003-03-12
KR100694005B1 (ko) 2007-03-12
AU2000233235A1 (en) 2001-09-17
ATE295735T1 (de) 2005-06-15
DE60020269D1 (de) 2005-06-23
EP1261367B1 (en) 2005-05-18
DK1261367T3 (da) 2005-09-12
EP1261367A1 (en) 2002-12-04
US7160860B2 (en) 2007-01-09
US20050090443A1 (en) 2005-04-28
JP2003525906A (ja) 2003-09-02
ES2241583T3 (es) 2005-11-01
CA2400711A1 (en) 2001-09-13
DE60020269T2 (de) 2006-01-19
SK12412002A3 (sk) 2002-12-03
PL356846A1 (en) 2004-07-12

Similar Documents

Publication Publication Date Title
PT1261367E (pt) Utilizacao de antagonistas da interleucina 6 para o tratamento de tumores dependentes de estrogenios
MXPA05010830A (es) Metodos de tratamiento que usan agentes de enlace especificos de angiopoyetina-2 humana.
YU37304A (sh) Specifični agensi koji vezuju humani angiopoetin-2
DK1663242T3 (da) 2,4-Pyrimidindiamin-forbindelser og anvendelse som antiproliferative midler
SE0102327D0 (sv) A novel engineered superantigen for human therapy
BR9811956B1 (pt) naftiridinonas e composição farmacêutica compreendendo as mesmas.
TW200612918A (en) Lonidamine analogs
MY135766A (en) Quinolinones and naphthyridinones for treating inflammatory diseases
MXPA05013822A (es) Pirrolodihidroisoquinolinas utiles en el tratamiento del cancer.
GB2394826A (en) Educational game
HN2001000217A (es) Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa - 7
GB0111186D0 (en) Novel compounds
EP1572087A4 (en) ANTIBODY TO CANCERANT TMEFF2 AND ITS APPLICATIONS
ATE288747T1 (de) Methoden und zusammensetzungen zur modulierung der aktivität von alpha-adrenergen rezeptoren
SI1622939T1 (sl) Akrivne variante il-18 vezavnega proteina in medicinske uporabe le-tega
AR024907A1 (es) Uso de inhibidores de la produccion y/o accion de la il-18 y composiciones farmaceuticas formuladas con dichos inhibidores para el tratamiento demetastasis de tumores.
AU2001233917A1 (en) Bcmp-7 as marker for diagnosis of breast cancer
DE59809283D1 (de) Inhibitoren für den urokinaserezeptor
ATE469659T1 (de) Stibogluconate-natrium und il-2 zur krebsbehandlung
ATE431742T1 (de) Modifizierte zytokine für krebs therapie
MY141606A (en) N-alkoxyalkyl-substituted benzimidazoles, their preparation and their use as agents against parasitic protozoa
DE60326348D1 (de) Makrozyclen zur behandlung von krebserkrankungen
DE60320422D1 (de) Verfahren und formulierungen, die sich für die reduktion des cholesteringehalts von eigelb eignen
MX2025005383A (es) Anticuerpos anti-beta-catenina
TW200635951A (en) Specific binding agents of human angiopoietin-2